Hjem › Neuroblastom › Minnesota
Kliniske studier for Neuroblastom i Minnesota
9 studier for Neuroblastom søker deltakere på steder i Minnesota.
Byer i Minnesota
Offisiell studietekst (engelsk)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
RekruttererFase 3
Opp til 30 år · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06172296Biomarkers of Resiliency In Childhood Cancer Surgery
- Mayo Clinic, Rochester
RekruttererObservasjonsstudie
Alder 3 til 25 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06674811Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Children's Hospital and Clinics of Minnesota, Minneapolis
RekruttererFase 2
Opp til 22 år · Alle kjønn · Oppdatert 4. sep. 2026 · NCT02559778Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
RekruttererFase 3
365 Days – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- University of Minnesota/Masonic Cancer Center, Minneapolis
RekruttererFase 1/2
12 Months – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Children's Hospital and Clinics of Minnesota, Minneapolis
RekruttererFase 2
12 Months – 21 Years · Alle kjønn · Oppdatert 12. aug. 2026 · NCT05489887Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Hospital and Clinics of Minn, Minneapolis
RekruttererFase 1/2
12 Months – 30 Years · Alle kjønn · Oppdatert 19. mai 2026 · NCT04901702Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- Masonic Cancer Center, University of Minnesota, Minneapolis
RekruttererFase 2
Opp til 30 år · Alle kjønn · Oppdatert 21. okt. 2025 · NCT02605421International PPB/DICER1 Registry
- Children's Minnesota, Minneapolis
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
0 Minutes – 100 Years · Alle kjønn · Oppdatert 30. jan. 2025 · NCT03382158Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.